HPLC Analysis Explained
High-performance liquid chromatography, or HPLC, separates sample components before a detector records their signals. An HPLC area-purity result describes the assigned main peak’s share of the included peak area under that method. It does not automatically establish identity, mass content or microbiological quality.
From a sample to a chromatogram
A liquid mobile phase carries the sample through a column containing a stationary phase. Components interact differently with those phases and can leave the column at different times. In reversed-phase HPLC, separation uses a relatively non-polar stationary phase and a more polar mobile phase. Changing the column or mobile phase can change the separation. [A5]
The detector records a response as material passes through. On a typical chromatogram, the horizontal axis shows time and the vertical axis shows detector response. A peak’s retention time tells you when it appeared in that run; integration estimates the area beneath it. Retention time depends on the method, so compare it only in that context. [A5]
How an area percentage is calculated
This deliberately simplified example contains three integrated peaks. The numbers are invented signal units, not a laboratory result, specification or measured impurity profile.
| Included peak | Integrated area | Share of total area |
|---|---|---|
| Assigned main peak | 900 | 90% |
| Peak B | 90 | 9% |
| Peak C | 10 | 1% |
| Total | 1,000 | 100% |
Main-peak area percentage = 900 ÷ (900 + 90 + 10) × 100 = 90%. The calculation itself does not identify B or C. Nor does it tell you how many milligrams are in the container. Uncorrected area normalisation uses signal proportions; an approximation to relative amounts requires appropriate detector-response assumptions. [A4]
Imagine that B and C were omitted from the integration. The same main-peak area would then produce 100%. This is an arithmetic illustration of why the denominator and integration rules matter, not an accusation about any laboratory. An interpretable report should make the included peaks and any exclusions clear.
Three limits behind a clean-looking trace
Co-elution: two components can emerge together and contribute to an unresolved peak. A single peak therefore does not establish a single chemical species. Suitability work should address the separations relevant to the method’s purpose; ICH Q2(R2) describes checking discrimination between closely eluting components. [A2]
Detector response: a UV detector depends on light absorption. Response varies with the compound and wavelength, and substances with inadequate response may be missed. Changing wavelength can change the observed profile. The stated detection wavelength is therefore part of the result, rather than a dispensable instrument detail. [A5]
Data processing: baseline placement, peak boundaries and integration settings determine the areas used in the calculation. Request the trace and integration table together. The chromatogram reading guide covers their interpretation. [A4]
An extra peak is evidence of an additional detected feature, not a structural identification. Common impurities introduces possible categories; assigning a particular impurity requires supporting analytical evidence.
HPLC can also measure content
HPLC is not restricted to area-purity reporting. A suitable quantitative method can compare sample response with calibration standards to measure content. The same broad technique may therefore support an assay or an impurity test, depending on its design and calculation. A report headed “HPLC” does not tell you which was performed. [A1]
Keep the distinction explicit when reviewing identity, purity and assay. An area percentage should not be converted into a content result unless the required quantitative basis is established.
What to request with the percentage
| Report detail | Why it helps interpretation |
|---|---|
| Sample and lot identifiers | Connects the chromatogram to the material being assessed. |
| Method identifier and version | Identifies the procedure rather than relying on “HPLC tested”. |
| Column, mobile-phase programme and detector settings | Establishes the conditions under which separation and detection occurred. |
| Chromatogram and integration table | Shows peak assignments, areas, exclusions and the calculation basis. |
| Suitability results and applicable criterion | Shows what the run was required to demonstrate before its result was accepted. |
| Identity evidence for the assigned main peak | Addresses which compound produced the signal. |
Use mass spectrometry to understand one possible identity method, including its own limits. A purity percentage alone does not prove identity.
For a Knockout Labs item, begin with the quality documentation hub and ask which records exist for the lot offered. The testing methods overview distinguishes the separate measurements. The 99%+ purity claim page explains why packaging wording needs lot-specific support.
References
Sources explain analytical principles. Pharmaceutical guidance is not evidence that a research material or supplier meets those standards. Examples on this page are hypothetical.
- [A1] ICH Q6A: Specifications: Test Procedures and Acceptance Criteria for New Drug Substances and New Drug Products: Chemical Substances. 1999. Sections 3.2.1(b–c), 3.2.2(b).
- [A2] ICH Q2(R2): Validation of Analytical Procedures. FDA publication, March 2024. Table 1; sections 3.1, 3.3 and glossary.
- [A4] Agilent OpenLab CDS: Data Analysis Reference Guide. February 2019, revision C. Integration chapters; printed pages 137–138, Area% and calibrated quantitation.
- [A5] Agilent: The LC Handbook, Guide to LC Columns and Method Development. n.d.. Essential concepts; printed pages 24–26 and 67.
Sources accessed 23 October 2026.